Stay updated with breaking news from Nasdaq Ards. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Free Report) was the recipient of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 2,000,000 shares, an increase of 8.1% from the June 15th total of 1,850,000 shares. Based on an average daily trading volume, of 3,360,000 […]
Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Free Report) was the recipient of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 2,000,000 shares, an increase of 8.1% from the June 15th total of 1,850,000 shares. Based on an average daily volume of 3,360,000 shares, […]
Aridis Pharmaceuticals (NASDAQ:ARDS – Get Rating) and Satsuma Pharmaceuticals (NASDAQ:STSA – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Profitability This table compares Aridis Pharmaceuticals and Satsuma Pharmaceuticals’ […]
Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Rating) was the target of a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 404,400 shares, a decrease of 29.5% from the April 15th total of 573,300 shares. Based on an average daily volume of 914,300 shares, the […]
LOS GATOS, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical...